EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zapatero, J.
Right arrow Articles by Candelas, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zapatero, J.
Right arrow Articles by Candelas, J.

European Journal of Cardio-Thoracic Surgery, Vol 3, 436-440, Copyright © 1989 by European Association for Cardio-thoracic Surgery


ARTICLES

Surgical treatment of thoracic hydatidosis. A review of 100 cases

J Zapatero, L Madrigal, J Lago, B Baschwitz, E Perez and J Candelas
Department of Thoracic Surgery, Hospital Ramon y Cajal, Madrid, Spain.

Hydatid cystic disease continues to hold an important place in chest disease in our country. The authors review their experience from 1977 to 1987 of 100 patients who underwent surgery for pulmonary hydatidosis. Mean age was 36.21 years. Fifty-nine cases were ruptured cysts (RC) and 41 were unruptured cysts (UC). The diagnosis was based on epidemiological, radiological and mainly serological and endoscopic criteria. The indirect haemagglutination test was positive in 100% of RC and 80% of UC, while 70.2% of the patients who underwent fiberoptic bronchoscopy showed pathological changes. The most commonly used surgical procedure in UC was open subtotal cystopericystectomy (89.09%), while wedge resection (41.81%) was the most commonly used technique for the RC. There were no operative deaths and no recurrences were observed for a mean follow-up of 5.4 years. The indications for adjuvant chemotherapy with mebendazole are presented.


This article has been cited by other articles:


Home page
Eur Respir JHome page
R. Morar and C. Feldman
Pulmonary echinococcosis
Eur. Respir. J., June 1, 2003; 21(6): 1069 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. K. Aribas, F. Kanat, N. Gormus, and E. Turk
Pleural complications of hydatid disease
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 492 - 497.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Athanassiadi, G. Kalavrouziotis, A. Loutsidis, I. Bellenis, and N. Exarchos
Surgical treatment of echinococcosis by a transthoracic approach: a review of 85 cases
Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 134 - 140.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.